- D68.32 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM D68.32 became effective on October 1, 2022.
- This is the American ICD-10-CM version of D68.32 – other international versions of ICD-10 D68.32 may differ.
ICD-10-CM D68.32 is grouped within Diagnostic Related Group(s):
- 813 Coagulation disorders
Applicable To
- Drug-induced hemorrhagic disorder
- Hemorrhagic disorder due to increase in anti-IIa
- Hemorrhagic disorder due to increase in anti-Xa
- Hyperheparinemia
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to D68.32:
- drug-induced (extrinsic) > Anticoagulant, circulating (intrinsic) D68.318
- iatrogenic > Anticoagulant, circulating (intrinsic) D68.318
- due to drugs > Circulating anticoagulants D68.318
- drug induced hemorrhagic > Disorder (of)
- drug-induced > hemorrhagic NEC D69.9
- due to > hemorrhagic NEC D69.9
- extrinsic circulating anticoagulants > due to D68.32
- increase in > due to D68.32
- anti-IIa > increase in D68.32
- anti-Xa > increase in D68.32